Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

16.0K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.0K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

9.7K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
9.7K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

3.4K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to letter to the editor: "GLP-1RAs for pouchitis in obesity: what the current study does not tell us".

Inflammatory bowel diseases·2026
Same author

Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma.

Leukemia·2026
Same author

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.

Frontiers in immunology·2026
Same author

Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: A Narrative Review.

Gastro hep advances·2026
Same author

BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistance.

Nature communications·2026
Same author

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Feb 16, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K

Smoldering mantle cell lymphoma.

Haige Ye1,2, Aakash Desai2,3, Dongfeng Zeng2

  • 1Department of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Journal of Experimental & Clinical Cancer Research : CR
|December 17, 2017
PubMed
Summary
This summary is machine-generated.

Identifying indolent Mantle Cell Lymphoma (MCL) is crucial for appropriate management. This study defines characteristics of a "Smoldering Mantle Cell Lymphoma" to guide treatment decisions.

Keywords:
Indolent MCLMantle cell lymphomaSmoldering lymphoma

More Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

859
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

20.5K

Related Experiment Videos

Last Updated: Feb 16, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

859
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

20.5K

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Mantle Cell Lymphoma (MCL) is typically aggressive with poor prognosis.
  • A subset of MCL patients exhibits indolent disease, surviving over 7-10 years with minimal symptoms.
  • Distinguishing indolent MCL is vital to avoid overtreatment and preserve quality of life.

Purpose of the Study:

  • To define criteria for identifying indolent Mantle Cell Lymphoma at diagnosis.
  • To propose a new classification for indolent MCL presentations.

Main Methods:

  • Review of clinical, immunophenotypic, and genetic features of indolent MCL cases.
  • Analysis of diagnostic markers including B symptoms, LDH, MIPI score, tumor size, and Ki-67.
  • Evaluation of specific immunophenotypes (CD5, CD38, CD23, CD200) and mutation status (C-myc, TP53, NOTCH1/2).

Main Results:

  • Indolent MCL characterized by lack of B symptoms, normal biomarkers, low MIPI, small tumor size, and specific immunophenotypes.
  • Absence of certain mutations (C-myc, TP53, NOTCH1/2) and non-blastoid histology are key indicators.
  • Indolent presentations include monoclonal B lymphocytosis, leukemic MCL, and in situ lymphoma.

Conclusions:

  • Distinct indolent MCL presentations possess unique cytologic and genetic profiles.
  • The term "Smoldering Mantle Cell Lymphoma" is proposed to encompass these indolent forms.
  • Accurate identification of smoldering MCL is essential for appropriate patient management.